Two Reyataz 200 mg capsules<unk>  is used in the treatment of HIV. The efficacy of<unk>  has been assessed in a number of well-designed trials in ART-naive and ART-experienced adults.<unk>  is distinguished from other protease inhibitors in that it has lesser effects on lipid profile and appears to be less likely to cause lipodystrophy. There may be some cross-resistant with other protease inhibitors. When boosted with ritonavir it is equivalent in potency to lopinavir for use in salvage therapy in people with a degree of drug resistance, although boosting with ritonavir reduces the metabolic advantages of<unk> . Pregnancy No evidence of harm has been found among pregnant women taking<unk> . It is one of the preferred HIV medications to use in pregnant women who have not taken an HIV medication before. It was not associated with any birth defects among over 2,500 live births observed.<unk>  resulted in a better cholesterol profile and confirmed that it is a safe option during pregnancy.
Atazanavir
Saquinavir
Indinavir
Ritonavir
Fosamprenavir
Entecavir
Coronavir
Abacavir